RLMD
Relmada Therapeutics Inc
3.80$
+1.1%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 98.3% | 98.3% | 90.8% | 87.2% | 89.8% | 99.8% | 99.9% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 92.1% | 92.1% | 83.0% | 60.3% | 73.5% | 31.0% | 2.1% | 19.9% | 3.5% | 4.2% | 8.4% | 3.7% | |
| 92.1% | 92.1% | 83.0% | 60.3% | 73.5% | 99.4% | 99.1% | 94.9% | 97.0% | 98.7% | 98.0% | 98.9% | |
| 0.3% | 0.3% | 2.6% | 10.3% | 2.4% | 0.1% | 0.1% | 0.0% | 0.3% | – | – | – | |
| – | 5.5% | 5.2% | 16.7% | 14.0% | 0.4% | 0.8% | 5.1% | 2.6% | – | – | – | |
| 0.1% | 2.2% | 0.0% | 0.4% | 0.2% | 0.0% | 0.0% | – | – | – | – | – | |
| 63.9% | 63.9% | 31.3% | 48.5% | 280.9% | 1.2% | 10.7% | 6.7% | 8.2% | 12.5% | 22.5% | 8.0% | |
| 63.9% | 63.9% | 29.9% | 48.5% | 193.7% | 1.2% | 10.7% | 6.7% | 8.2% | 12.5% | 22.5% | 6.8% | |
| 1.1% | 1.1% | 2.7% | 9.8% | 9.4% | 0.1% | – | – | – | – | – | – | |
| 3.4% | 3.4% | 12.3% | 18.7% | 25.1% | 0.4% | 7.1% | 5.0% | 3.4% | 3.6% | 9.0% | 1.7% | |
| – | – | – | 93.6% | – | – | – | – | – | – | – | – | |
| 36.1% | 36.1% | 68.7% | 51.5% | -180.9% | 98.8% | 89.3% | 93.3% | 91.8% | 87.5% | 77.5% | 92.0% | |
| -312.1% | -312.1% | -772.1% | -3,009.7% | -3,095.2% | -102.3% | -151.7% | -136.6% | -302.2% | -575.0% | -1,398.8% | -742.8% | |
| 10.2% | 10.2% | 28.3% | 106.4% | 102.9% | 7.9% | 13.2% | 7.9% | 19.4% | 30.9% | 65.8% | 42.0% |
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.